KLKa Hou Christien Li

Ka Hou Christien Li

*This is an algorithmically generated author record based on publicly available information.

Current Organizations / Institutes

The organizations/institutes from the scholar's latest article

Previous Organizations / Institutes

The organizations / institutes from the scholar's other articles in the past ten years


Ka Hou Christien Li has a total of 31 co-authors. Here are the top co-authors by number of shared publications:


Latest Publications

  • Open Access

    Efficacy and cardiac safety of aldoxorubicin in metastatic solitary fibrous tumour

    by Karolina Vosylius, Gareth Price, Andrea Napolitano, Charlotte Benson, Nicos Fotiadis, Khin Thway, Ka Hou Christien Li, Robin L Jones

    Solitary fibrous tumours (SFT) are very rare mesenchymal neoplasms. While surgery remains a standard treatment for localised disease, effective and long term treatment options for metastatic disease are lacking, making the use of aldoxorubicin a novel and promising systemic treatment in SFTs. We present a 30-year-old male who underwent surgical resection for a solitary fibrous tumour of the right leg. Postoperative imaging revealed metastatic disease in the liver and left upper quadrant. He was initially treated with pazopanib but experienced disease progression after 24 weeks. The patient was then enrolled on a phase III trial evaluating aldoxorubicin for advanced soft tissue sarcomas and received 350 mg/m 2 (260 mg/m 2 doxorubicin equivalent) intravenously every 21 days, cumulative dose being 9100 mg/m 2 . Treatment was well tolerated, with manageable toxicities including alopecia, leukopenia, mucositis, and grade 3 neutropenia requiring G-CSF support. Notably, serial echocardiograms showed no evidence of cardiotoxicity, with a preserved ejection fraction (56–65%). He completed 26 cycles with stable disease, followed by a 7-month treatment break before receiving compassionate-use aldoxorubicin. Disease stability persisted for 6 months until progression, which was treated with radiotherapy. Three months later, systemic progression led to treatment discontinuation. This case illustrates the favourable cardiac safety profile of aldoxorubicin and efficacy in solitary fibrous tumours.


  • Open Access

    Acute ischemic stroke management: concepts and controversies.A narrative review

    by Ka Hou Christien Li, Aaron Jesuthasan, Christopher Kui, Ruth Davies, Gary Tse, Gregory Y. H. Lip

    Amongst the 25.7 million survivors and 6.5 million deaths from stroke between 1990 and 2013, ischemic strokes accounted for approximately 70% and 50% of the cases, respectively. With patients still...


  • Safety and Tolerability of Subcutaneous Methotrexate in Routine Clinical Practice

    by Christien K. H. Li, Kenneth Baker, Tania Jones, Elizabeth Coulson, Andrew Roberts, Fraser Birrell

    Objective: To show the safety and efficacy of subcutaneous (SC) methotrexate (MTX) compared to oral MTX, alternative disease‐modifying antirheumatic drugs (DMARDs) monotherapy, biologic monotherapy, and combinations (conventional and biologic combination groups) in routine clinical practice.Methods: Clinical and laboratory data were retrospectively analyzed for rheumatology clinic attendances at a large Northeast England hospital trust between January 2014 and January 2018. Rates of adverse events and stop events (transaminitis [serum alanine aminotransferase level of >80 units/liter] or neutropenia [neutrophil count of 9/liter]) were calculated, with adjustment for duration of DMARD exposure.Results: In the present study, 8,394 patients received DMARDs, with 2,093 patients receiving oral MTX and 949 patients receiving SC MTX. The median dose was 15 mg (interquartile range [IQR] 10–20 mg) for oral MTX, and 20 mg (IQR 15–25 mg) for SC MTX (P < 0.0001). Continuation rates were higher for SC MTX therapy when adjusted for follow‐up duration, with a rate ratio (RR) of 1.54 (95% confidence interval [95% CI] 1.40–1.70) (P < 0.0001). For the time period assessed, 2,382 patients experienced 4,358 adverse events, with 1,711 incidents of transaminitis and 2,647 incidents of neutropenia recorded. Significantly fewer adverse events were observed in patients who received SC MTX monotherapy versus those who received biologic and combination DMARD therapies (P < 0.01). Compared to oral MTX, SC MTX was associated with a nonsignificant trend toward lower rates of neutropenia, but only a slightly higher rate of transaminitis (RR 1.26 [95% CI 1.07–1.48]) (P = 0.006), despite significantly higher doses of MTX.Conclusion: Subcutaneous MTX is safe in routine clinical practice. This is the largest study yet reported on SC MTX and provides observational data that SC MTX is continued longer and better tolerated in patients compared to other therapy groups, especially oral MTX.


  • Open Access

    The Current State of Mobile Phone Apps for Monitoring Heart Rate, Heart Rate Variability, and Atrial Fibrillation: Narrative Review

    by Ka Hou Christien Li, Francesca Anne White, Timothy Tipoe, Tong Liu, Martin Cs Wong, Aaron Jesuthasan, Adrian Baranchuk, Gary Tse, Bryan P Yan

    Journal of Medical Internet Research - International Scientific Journal for Medical Research, Information and Communication on the Internet #Preprint #PeerReviewMe: Warning: This is a unreviewed preprint. Readers are warned that the document has not been peer-reviewed by expert/patient reviewers or an academic editor, may contain misleading claims, and is likely to undergo changes before final publication, if accepted, or may have been rejected/withdrawn. Readers with interest and expertise are encouraged to sign up as peer-reviewer, if the paper is within an open peer-review period. Please cite this preprint only for review purposes or for grant applications and CVs (if you are the author). Smartphone applications capable of monitoring arrhythmias and heart rate are becoming widely available. These applications involve the use of photoplethysmography and recording through a hand-held external electrocardiographic recording device attached to the smartphone or wristband. This enables recordings to be obtained for analysis, which could be useful for screening, diagnosis and monitoring of heart rate and rhythm disorders. We conducted a narrative review into the use of smartphone devices by searching PubMed and Embase from their inception to April 2018. Potentially relevant papers were then compared against a checklist for relevance and reviewed independently for inclusion, with the focus on four allocated topics of i) smartphone monitoring, ii) atrial fibrillation, iii) heart rate and iv) heart rate variability.


  • Open Access

    Figure Correction: Resting and Postexercise Heart Rate Detection From Fingertip and Facial Photoplethysmography Using a Smartphone Camera: A Validation Study

    by Bryan P Yan, Christy Ky Chan, Christien Kh Li, Olivia Tl To, William Hs Lai, Gary Tse, Yukkee C Poh, Ming-Zher Poh

    Mobile and tablet apps, ubiquitous and pervasive computing, wearable computing and domotics for health.


  • Open Access

    The Current State of Mobile Phone Apps for Monitoring Heart Rate, Heart Rate Variability, and Atrial Fibrillation: Narrative Review (Preprint)

    by Ka Hou Christien Li, Francesca Anne White, Timothy Tipoe, Tong Liu, Martin Cs Wong, Aaron Jesuthasan, Adrian Baranchuk, Gary Tse, Bryan P Yan

    BACKGROUND Mobile phone apps capable of monitoring arrhythmias and heart rate (HR) are increasingly used for screening, diagnosis, and monitoring of HR and rhythm disorders such as atrial fibrillation (AF). These apps involve either the use of (1) photoplethysmographic recording or (2) a handheld external electrocardiographic recording device attached to the mobile phone or wristband. OBJECTIVE This review seeks to explore the current state of mobile phone apps in cardiac rhythmology while highlighting shortcomings for further research. METHODS We conducted a narrative review of the use of mobile phone devices by searching PubMed and EMBASE from their inception to October 2018. Potentially relevant papers were then compared against a checklist for relevance and reviewed independently for inclusion, with focus on 4 allocated topics of (1) mobile phone monitoring, (2) AF, (3) HR, and (4) HR variability (HRV). RESULTS The findings of this narrative review suggest that there is a role for mobile phone apps in the diagnosis, monitoring, and screening for arrhythmias and HR. Photoplethysmography and handheld electrocardiograph recorders are the 2 main techniques adopted in monitoring HR, HRV, and AF. CONCLUSIONS A number of studies have demonstrated high accuracy of a number of different mobile devices for the detection of AF. However, further studies are warranted to validate their use for large scale AF screening.


  • Open Access

    Figure Correction: Resting and Postexercise Heart Rate Detection From Fingertip and Facial Photoplethysmography Using a Smartphone Camera: A Validation Study (Preprint)

    by Bryan P Yan, Christy Ky Chan, Christien Kh Li, Olivia Tl To, William Hs Lai, Gary Tse, Yukkee C Poh, Ming-Zher Poh

    Journal of Medical Internet Research - International Scientific Journal for Medical Research, Information and Communication on the Internet #Preprint #PeerReviewMe: Warning: This is a unreviewed preprint. Readers are warned that the document has not been peer-reviewed by expert/patient reviewers or an academic editor, may contain misleading claims, and is likely to undergo changes before final publication, if accepted, or may have been rejected/withdrawn. Readers with interest and expertise are encouraged to sign up as peer-reviewer, if the paper is within an open peer-review period. Please cite this preprint only for review purposes or for grant applications and CVs (if you are the author).

  • Open Access

    Atypical electrocardiographic manifestations of ischemia: a case of dynamic Wellens patterns

    by Alex Tsz Lai Ngan, Cynthia Yeung, Lorraine Chiang, Tong Liu, Gary Tse, Ka Hou Christien Li


  • Open Access

    Resting and Postexercise Heart Rate Detection From Fingertip and Facial Photoplethysmography Using a Smartphone Camera: A Validation Study

    by Bryan P Yan, Christy Ky Chan, Christien Kh Li, Olivia Tl To, William Hs Lai, Gary Tse, Yukkee C Poh, Ming-Zher Poh

    Mobile and tablet apps, ubiquitous and pervasive computing, wearable computing and domotics for health.